InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Dare Bioscience, Inc.

DARE Clue Score27
United States Fiscal year ends December CIK 0001401914
$0.77 +0.16% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.77 −52.26% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.8Operating income−0.6Net income−0.7Fiscal year 2017Operating income−11.2Net income−11.5Fiscal year 2018Operating income−16.9Net income−16.7Fiscal year 2019Operating income−14.3Net income−14.3Fiscal year 2020Operating income−27.4Net income−27.4EPS, diluted−0.91Fiscal year 2021Revenue0.0Operating income−39.1Net income−38.7EPS, diluted−0.63Fiscal year 2022Revenue10.0Operating income−31.4Net income−30.9EPS, diluted−0.37Fiscal year 2023Revenue2.8 −71.9%Operating income−30.9Net income−30.2EPS, diluted−4.15Fiscal year 2024Revenue0.0 −99.7%Operating income−23.5Net income−4.1EPS, diluted−0.48Fiscal year 2025Revenue1.0 +10,429.4%Operating income−13.6Net income−13.4EPS, diluted−1.20
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.8 n/a n/a n/a n/a 0.0 10.0 2.8 0.0 1.0
Growth −71.9% −99.7% +10,429.4%
Operating income −0.6 −11.2 −16.9 −14.3 −27.4 −39.1 −31.4 −30.9 −23.5 −13.6
Net income −0.7 −11.5 −16.7 −14.3 −27.4 −38.7 −30.9 −30.2 −4.1 −13.4
Growth
EPS, diluted n/a n/a n/a n/a −0.91 −0.63 −0.37 −4.15 −0.48 −1.20

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−82.3%Net margin−87.8%Free cash flow margin−118.4%Fiscal year 2017Fiscal year 2018Fiscal year 2019Fiscal year 2020Fiscal year 2021Fiscal year 2022Operating margin−313.9%Net margin−309.5%Free cash flow margin−181.5%Fiscal year 2023Operating margin−1,101.9%Net margin−1,074.2%Free cash flow margin−1,406.3%Fiscal year 2024Operating margin−239,692.2%Net margin−41,430.9%Free cash flow margin50,087.0%Fiscal year 2025Operating margin−1,315.5%Net margin−1,300.7%Free cash flow margin−997.0%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −82.3% n/a n/a n/a n/a n/a −313.9% −1,101.9% −239,692.2% −1,315.5%
Net margin −87.8% n/a n/a n/a n/a n/a −309.5% −1,074.2% −41,430.9% −1,300.7%
Free cash flow margin −118.4% n/a n/a n/a n/a n/a −181.5% −1,406.3% 50,087.0% −997.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−0.4Capital expenditure−0.5Free cash flow−0.9Fiscal year 2017Operating cash flow−2.5Capital expenditure0.0Free cash flow−2.5Fiscal year 2018Operating cash flow−10.3Capital expenditure−0.0Free cash flow−10.3Fiscal year 2019Operating cash flow−13.3Capital expenditure0.0Free cash flow−13.3Fiscal year 2020Operating cash flow−25.2Capital expenditure−0.0Free cash flow−25.3Fiscal year 2021Operating cash flow−28.8Capital expenditure−0.0Free cash flow−28.8Fiscal year 2022Operating cash flow−18.1Capital expenditure−0.1Free cash flow−18.2Fiscal year 2023Operating cash flow−38.9Capital expenditure−0.6Free cash flow−39.5Fiscal year 2024Operating cash flow5.5Capital expenditure−0.6Free cash flow4.9Fiscal year 2025Operating cash flow−9.9Capital expenditure−0.4Free cash flow−10.3 −309.6%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −0.4 −2.5 −10.3 −13.3 −25.2 −28.8 −18.1 −38.9 5.5 −9.9
Capital expenditure −0.5 0.0 −0.0 0.0 −0.0 −0.0 −0.1 −0.6 −0.6 −0.4
Free cash flow −0.9 −2.5 −10.3 −13.3 −25.3 −28.8 −18.2 −39.5 4.9 −10.3
Growth −309.6%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash0.0Shareholders’ equity−0.7Fiscal year 2017Cash7.6Shareholders’ equity13.3Fiscal year 2018Cash6.8Shareholders’ equity6.7Fiscal year 2019Cash4.8Shareholders’ equity0.4Fiscal year 2020Cash4.7Shareholders’ equity−1.2Fiscal year 2021Cash51.7Shareholders’ equity38.8Fiscal year 2022Cash34.7Shareholders’ equity11.1Fiscal year 2023Cash10.5Shareholders’ equity−5.0Fiscal year 2024Cash15.7Total debt0.0Net cash (debt)15.7Shareholders’ equity−6.0Fiscal year 2025Cash24.7Shareholders’ equity2.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.0 7.6 6.8 4.8 4.7 51.7 34.7 10.5 15.7 24.7
Total debt n/a n/a n/a n/a n/a n/a n/a n/a 0.0 n/a
Net cash (debt) n/a n/a n/a n/a n/a n/a n/a n/a 15.7 n/a
Shareholders’ equity −0.7 13.3 6.7 0.4 −1.2 38.8 11.1 −5.0 −6.0 2.8

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
−82.3% n/a n/a n/a n/a n/a −313.9% −1,101.9% −239,692.2% −1,315.5%
−87.9% n/a n/a n/a n/a n/a −309.5% −1,074.1% −41,414.6% −1,314.4%
−87.8% n/a n/a n/a n/a n/a −309.5% −1,074.2% −41,430.9% −1,300.7%
−118.4% n/a n/a n/a n/a n/a −181.5% −1,406.3% 50,087.0% −997.0%
Spending
9.5% n/a n/a n/a n/a n/a 300.4% 767.1% 146,210.2% 536.1%
20.6% n/a n/a n/a n/a n/a 112.4% 431.3% 93,582.0% 850.7%
69.8% n/a n/a n/a n/a n/a 0.6% 22.4% 5,857.0% 37.4%
Returns
n/a −86.5% −248.8% −3,235.7% n/a −99.8% −278.5% n/a n/a −471.4%
−1,507.8% −80.7% −213.8% −191.6% −362.9% −69.3% −70.6% −141.7% −18.3% −41.3%
Balance and payout
1,692.8% 6.8% 14.1% 94.1% 115.3% 30.6% 74.6% 123.7% 127.2% 91.2%